InvestorsHub Logo

rocketeer357

08/26/10 8:44 AM

#379 RE: surf1944 #378

Very nice news..and the run up the past few days strongly suggests that, once again, lots of folks knew the deal was happening before us small fry.

Nice payday, nice validation of stacatto, nice residuals (10% of net) down the road.

Hope to see a floor under 3$ today and not a sell off on the news.

surf1944

08/31/10 4:48 PM

#391 RE: surf1944 #378

Alexza Pharmaceuticals(ALXA)
Drug/indication: AZ-004 for agitation in patients with schizophrenia or bipolar disorder
Approval decision date: Oct. 11, 2010
Recent stock performance: At around $3, stock is still far from the 52-week high of nearly $4 reached in May.
AZ-004 is an inhaled formulation of the generic antispsychotic drug loxapine, intended for the rapid treatment of adults with schizophrenia or bipolar disorder. Biovail(BVF) will market AZ-004 in the U.S. and Canada, if approved.

http://www.thestreet.com/story/10847027/3/21-drugs-facing-fda-approval-decisions.html